U.S. FDA Authorizes InteliSwab™ COVID-19 Rapid Tests for OTC Single-Use, At-Home Testing for Symptomatic People and Accepts Data for Delta Variant Detection

Source: Nasdaq GlobeNewswire / 02 Nov 2021 07:05:00   America/New_York